SAM
Sectoral Asset Management Portfolio holdings
AUM
$151M
This Quarter Return
+29.39%
1 Year Return
+14.02%
3 Year Return
+79.35%
5 Year Return
+153.48%
10 Year Return
+511.68%
AUM
$1.42B
AUM Growth
+$1.42B
(+22%)
Cap. Flow
+$99.8M
Cap. Flow
% of AUM
7.03%
Top 10 Holdings %
Top 10 Hldgs %
29.29%
Holding
112
New
24
Increased
30
Reduced
36
Closed
15
Top Buys
| 1 |
Atea Pharmaceuticals
AVIR
|
$62.3M |
| 2 |
Maravai LifeSciences
MRVI
|
$27.5M |
| 3 |
Replimune Group
REPL
|
$25.5M |
| 4 |
Tandem Diabetes Care
TNDM
|
$23.8M |
| 5 |
Certara
CERT
|
$20.4M |
Top Sells
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$51M |
| 2 |
HMSY
HMS Holdings Corp.
HMSY
|
$18.7M |
| 3 |
Zentalis Pharmaceuticals
ZNTL
|
$18.2M |
| 4 |
BPMC
Blueprint Medicines
BPMC
|
$17.7M |
| 5 |
Assembly Biosciences
ASMB
|
$15.1M |
Sector Composition
| 1 | Healthcare | 96.8% |
| 2 | Industrials | 1.99% |
| 3 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Pfizer
PFE
$141B
| $3.49M | 0.25% |
94,900
-17,000
| -15% | -$848K |
|
|
NCNA
77
NuCana
NCNA
$5.8M
| $3.37M | 0.24% |
750,000
| – | – |
|
78
Biogen
BIIB
$20.8B
| $3.13M | 0.22% |
12,782
-9,850
| -44% | -$2.41M |
|
79
Regeneron Pharmaceuticals
REGN
$59.8B
| $2.23M | 0.16% |
4,620
-18,310
| -80% | -$8.85M |
|
|
MTEM
80
DELISTED
Molecular Templates, Inc.
MTEM
| $2.11M | 0.15% |
224,500
+45,000
| +25% | +$423K |
|
81
Sotera Health
SHC
$4.54B
| $2.05M | 0.14% |
+74,618
| New | +$2.05M |
|
82
Stryker
SYK
$149B
| $1.91M | 0.13% |
+7,800
| New | +$1.91M |
|
83
Boston Scientific
BSX
$159B
| $1.81M | 0.13% |
50,226
-326,761
| -87% | -$11.7M |
|
84
Gilead Sciences
GILD
$140B
| $1.72M | 0.12% |
29,550
-35,350
| -54% | -$2.06M |
|
85
Danaher
DHR
$143B
| $1.67M | 0.12% |
7,500
| – | – |
|
86
Illumina
ILMN
$15.2B
| $1.51M | 0.11% |
4,070
-775
| -16% | -$287K |
|
87
Aprea Therapeutics
APRE
$8.91M
| $805K | 0.06% |
163,681
-752,000
| -82% | -$3.7M |
|
88
Incyte
INCY
$17B
| $752K | 0.05% |
8,640
-130,134
| -94% | -$11.3M |
|
89
argenx
ARGX
$44.2B
| $735K | 0.05% |
2,500
| – | – |
|
|
HZNP
90
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $693K | 0.05% |
+9,475
| New | +$693K |
|
91
Zai Lab
ZLAB
$3.48B
| $528K | 0.04% |
3,900
+1,200
| +44% | +$162K |
|
92
Aligos Therapeutics
ALGS
$75.1M
| $517K | 0.04% |
+18,708
| New | +$517K |
|
93
Dr. Reddy's Laboratories
RDY
$11.8B
| $460K | 0.03% |
6,454
+1,100
| +21% | +$78.4K |
|
94
BridgeBio Pharma
BBIO
$9.91B
| $427K | 0.03% |
+6,000
| New | +$427K |
|
|
KLRS
95
Kalaris Therapeutics, Inc. Common Stock
KLRS
$85.5M
| $375K | 0.03% |
9,746
-268,049
| -96% | -$10.3M |
|
96
Kodiak Sciences
KOD
$453M
| $242K | 0.02% |
+1,650
| New | +$242K |
|
97
4D Molecular Therapeutics
FDMT
$302M
| $217K | 0.02% |
+5,224
| New | +$217K |
|
|
TRHC
98
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| – | – |
-35,177
| Closed | -$1.43M |
|
|
AMED
99
DELISTED
Amedisys
AMED
| – | – |
-15,825
| Closed | -$3.74M |
|
|
100
Assembly Biosciences
ASMB
$183M
| – | – |
-916,185
| Closed | -$15.1M |
|